Endocrine System - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Endocrine System

Description:

Endocrine System Small group of organs with a principal function of secreting hormones Hormones have regulatory effects on metabolic and biochemical processes ... – PowerPoint PPT presentation

Number of Views:237
Avg rating:3.0/5.0
Slides: 36
Provided by: Stud107
Category:
Tags: endocrine | system

less

Transcript and Presenter's Notes

Title: Endocrine System


1
Endocrine System
  • Small group of organs with a principal function
    of secreting hormones
  • Hormones have regulatory effects on metabolic and
    biochemical processes throughout the body
  • Endocrine glands consists of
  • gtpituitary gland (anterior/posterior)
  • gtthyroid gland
  • gtparathyroid gland
  • gtislet cells of the pancreas
  • gtadrenal glands (cortex/medulla)
  • gtgonads (ovaries/testes)

2
Endocrine System
  • In-vivo imaging and non-imaging applications in
    NM has a significant role in understanding the
    function and disorders of the endocrine system
  • Thyroid, parathyroid, and adrenal glands most
    common.
  • No other imaging or non-imaging procedures exists
    for other glands

3
Adrenal Gland Imaging
  • Located at superior poles of the kidneys.
  • Consist of outer cortex and inner medulla
  • Cortex produces steroid hormones
    (aldosterone,cortisol)
  • Medulla manufactures catecholamines
    (epinephrine/norepinephrine) hormones that
    control bodies response to stress

4
Adrenal Gland Imaging
  • Tumors of the adrenal medulla sre called
    Pheochromocytomas
  • Symptoms include increased levels of
    epinephrine/non-epinephrine in blood and urine.
  • NM used to identify sites of increased
    epinephrine/norepinephrine within adrenal bed and
    outside metastatic sites.

5
Adrenal Gland Imaging
  • Radiopharmaceutical used to image the adrenal
    medulla is I-131 methyliodobenzylguanidine (MIBG)
  • Compound is structurally the same as
    norepinephrine, does not exert same effect.

6
Adrenal Gland Imaging
  • 1 day prior to injection, patient prep receives
    Lugols solution (potassium iodide)
  • Solution saturates the thyroid gland preventing
    uptake of I-131 (minimize unnecessary exposure to
    thyroid)
  • 0.5mCi I-131 administered IV.

7
Adrenal Gland Imaging
  • Anterior and Posterior images acquired at 1,3,
    and 7 days PI. (skull to pelvis)
  • Patient is asked to void prior to study.
  • Uptake normally in liver, spleen, and heart.
  • Salivary glands and bladder may also be
    visualized.

8
Adrenal Gland Imaging
  • Metastases from Pheochromocytomas may be
    visualized in liver, bone, lymph nodes, heart,
    and lungs.

9
Thyroid Imaging
  • Located in the anterior neck between suprasternal
    notch and thyroid cartilage.
  • Consists of 2 lobes approx 3-4 cm long.
  • Isthmus connects lobes. Thyroid overlies trachea
  • Highly vascular (superior/inferior thyroid
    arteries)

10
Thyroid Imaging
  • Thyroid imaging is one of the earliest NM
    procedures developed
  • Based on physiological process of thyroid hormone
    production T-3(triiodothyronine) T-
  • 4(tetraiodothyronine)

11
Thyroid Imaging
  • T-3 and T-4 are products of iodine absorbed into
    the blood from digestion.
  • Blood transports iodine in the form of iodide to
    the thyroid gland.
  • Iodide is trapped by thyroid follicular cells.
  • Process is called iodide pump.

12
Thyroid Imaging
  • Hormones produced in the thyroid are stored there
    until they are required by body.
  • Thyroid controls many metabolic processes growth
    and development, body temperature regulation,
    metabolism of proteins, lipids, carbohydrates,
    vitamins, and minerals.

13
Thyroid Imaging
  • Thyroid hormone production and secretion
    controlled by negative feedback.
  • TSH (thyroid stimulating hormone) released by
    pituitary gland, regulates thyroid iodide uptake
    and release.

14
Clinical Indications
  • Evaluate gland structure to function
  • Evaluate gland size and palpable nodules or
    masses.
  • Identify ectopic thyroid tissue located from base
    of tongue to below sternum.

15
Thyroid Imaging procedure
  • Prior to dose administration patient should be
    questioned previous thyroid surgery,thyroid
    symptoms, thyroid medications, recent
    radiographic procedures.
  • Many medications, iodine containing foods, and
    radiographic procedures using iodinated contrast
    can affect radioiodine uptake.

16
Thyroid Imaging procedure
  • All females of chidbearing age should be
    questioned
  • Lab values for thyroid hormones will aid in
    interpretation.
  • Radiopharmaceuticals administered orally or
    intravenously
  • Tc99m is tracer administered IV and imaging
    begins 15-30min PI.

17
Thyroid Imaging Procedure
  • I-123 sodium iodide is administered orally and
    imaged 3-4hrs or 16-24hrs.after administration
  • I-131 sodium iodide is administered orally and
    imaged 6-24hrs after administration
  • Patient placed supine with neck hyperextended.

18
Thyroid Imaging procedure
  • Pinhole or LEHR collimator used for imaging
  • Images are acquired in the anterior and oblique
    projections
  • Marker images acquired anteriorly at supersternal
    notch and over thyroid cartlidge.
  • Ectopic thyroid tissue suspected an anterior view
    of mediastinum is obtained

19
(No Transcript)
20
Thyroid Imaging Procedure
  • Normal findings
  • gtbutterfly shaped structure with a uniform
    symmetric distribution of activity
  • gtright lobe slightly larger than left
  • gtisthmus not well defined
  • gtpyramidal (third lobe) may be visualized.

21
Thyroid Imaging Procedure
  • Abnormal findings
  • gtenlarged thyroid gland
  • gtvisualization of functioning and
    non-functioning thyroid nodules
  • gtfunctioning HOT nodules represent benign
    cysts or tumors
  • gtnon-functioning COLD nodules represent
    carcinoma, benign adenoma, cysts, hematoma,
    inflammatory condotions.

22
Thyroid Uptake Procedure
  • If using I-123 or I-131 capsules a thyroid uptake
    is obtained
  • Measures amount of radioactive iodide that is
    taken and retained within thyroid gland.
  • Uptake at 2-6hrs measures iodine trapping
  • Uptake at 24-48hrs measures rate of iodine is
    lost from gland

23
Thyroid Uptake Procedure
  • I-123 and I-131 in capsule or liquid form (most
    common capsule)
  • Preferred thyroid uptake, possible with Tc99m.
  • Patient preparation same as radioiodine thyroid
    imaging
  • NPO and fasting 2hrs post administration
  • Data (uptake) collected with thyroid uptake probe
    (sodium iodide crystal flat field collimator)

24
Thyroid Uptake Procedure
  • Thyroid gland counts are collected with patient
    in supine or seated (erect) position
  • Neck is hyperextended, probe over centered
    between suprasternal notch and thyroid cartlidge.

25
Thyroid Uptake Procedure
  • Thyroid uptake calculations are obtained by
    Patient counts from the neck and patient
    background.
  • Counts from standard (capsule) and room
    background
  • 1min counts are obtained for each.
  • Normal values 4hrs 6-18
  • 24hrs 10-35

26
Radioiodine Whole-body Imaging
  • Post thyroid-ectomy (carcinoma) whole body
    radioiodine imaging is acquired
  • To identify remaining residual thyroid tissue or
    metastasis.
  • I-131 sodium iodide most commonly used.
  • 1-10mCi I-131 administered orally

27
Radioiodine whole body Imaging
  • Patient preparation similar to thyroid imaging
  • Anterior and posterior images of body from head
    to mid-femur acquired.
  • 24-48 hrs post administration
  • Anatomical landmarks placed on images, activity
    seen in salivary glands, thyroid tissue remnants,
    stomach, esophagus, functioning metastasis.

28
Parathyroid Imaging
  • 4 parathyroid glands located on posterior aspect
    of poles of thyroid gland
  • Produce and secrete parathyroid hormone (PTH)
  • Responsible for regulating level and distribution
    of calcium and phosphorus.

29
Parathyroid Imaging
  • Imaging useful when primary hyperthyroidism is
    suspected.
  • Tumor in one of the parathyroid glands or
    hyperplasia of all four glands lead to excess PTH
    to be secreted.
  • PTH stimulates the removal of calcium from bones,
    affects nervous system, muscle contraction, etc.
  • Treatment is surgical removal of hyperplastic
    gland or tumor

30
Parathyroid Imaging
  • Parathyroid imaging acquired with either dual
    phase or dual tracer technique
  • dual phase Tc99m sestamibi 5-25 mCi is
    administered
  • localizes in both thyroid/parathyroid tissue
  • tracer washes out of normal thyroid tissue
    quicker than abnormal parathyroid tissue

31
Parathyroid Imaging
  • Imaging 10min PI and again 1.5hr-2.5hr PI is
    obtained
  • Abnormal parathyroid demonstrates retention of
    tracer, becomes better visualized on delay
    images.

32
Parathyroid Imaging
  • Dual tracer technique
  • Tc99m or I-123 sodium iodide (distinguish normal
    thyroid tissue)
  • Tc99m-sestamibi or thallium-201 (localizes in
    both thyroid and abnormal parathyroid tissue)
  • Advantages/Disadvantages
  • scatter high energy to low energy
  • length of images (pt.cooperation)
  • activity of each tracer/time required for
    I123 to localize.

33
Parathyroid Imaging
  • Both images are normalized, so counts per pixel
    are the same for both images.
  • Tc99m/I-123 images are subtracted from Tc99m
    sestamibi/thallium-201 images.
  • Final images reveal area of abnormal parathyroid.

34
Parathyroid Imaging
  • Dual phase techniques has several advantages
  • One injection and tracer (Tc99m sestemibi)
  • No computer subtraction needed
  • Radiation dose decreased to patient.

35
TURN ON THE LIGHTS
  • ANY QUESTIONS???????
Write a Comment
User Comments (0)
About PowerShow.com